Bnp Paribas Asset Management Holding S.A. Ascendis Pharma A/S Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 316,580 shares of ASND stock, worth $53.2 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
316,580
Previous 243,856
29.82%
Holding current value
$53.2 Million
Previous $36.4 Million
19.7%
% of portfolio
0.11%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding ASND
# of Institutions
235Shares Held
59.5MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.7 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$929 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$857 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$748 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$736 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.38B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...